Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adverum Biotechnologies, Inc. | Chief Technology Officer | Common Stock | 150K | $232K | $1.55 | Aug 6, 2021 | Direct |
Adverum Biotechnologies, Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 120K | Aug 6, 2021 | Direct | ||
Nkarta, Inc. | Director | Stock Option (right to buy) | 22.5K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKTX | Nkarta, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
NKTX | Nkarta, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
NKTX | Nkarta, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
NKTX | Nkarta, Inc. | Mar 28, 2022 | 1 | $0 | 4 | Mar 29, 2022 | Director |
NKTX | Nkarta, Inc. | Mar 28, 2022 | 0 | $0 | 3 | Mar 29, 2022 | Director |
ADVM | Adverum Biotechnologies, Inc. | Aug 6, 2021 | 2 | $0 | 4 | Aug 10, 2021 | Chief Technology Officer |